At a glance
ClinicalIndex Comparison RecordN/ACompleted· 108 enrolled
Drug / intervention
VIZO Glassesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Assess the Efficacy and Safety of a Novel Device (VIZO Glasses) in the Management of ADHD in Adults
In Brief
A clinical study evaluating VIZO Glasses for ADHD. Completed, enrolled 108 participants across 1 site.
Detailed Summary
This is a 2-months study, where eligible ADHD adult participants will be provided with personalized VIZO glasses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsADHD
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartApr 2022
Primary CompletionMar 2023
First PostedMar 2023
Study CompletionMar 2023
TodayJul 2026
First PostedMar 21, 2023
Enrollment StartApr 1, 2022
Primary CompletionMar 1, 2023
Study CompletionMar 26, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.3 years ago
Interventions
VIZO Glassesdevice
Eyeglasses with personalized peripheral retinal stimuli